Lista de obras -

Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms

artículo científico publicado en 2012

Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms ⬇️

artículo científico publicado el 14 de mayo de 2012

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

artículo científico publicado en 2015

Age cutoff in lymphoma diagnosis.

artículo científico publicado en 2015

American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma

artículo científico publicado en 2019

Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients

scientific article published on 26 June 2019

Characterization of TP53 mutations in clonal cytopenia of undetermined significance.

artículo científico publicado en 2017

Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype

artículo científico publicado en 2017

Checkpoint inhibitors in hematological malignancies

artículo científico publicado en 2017

Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption

scientific article published on 04 August 2018

Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1

artículo científico publicado en 2020

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

artículo científico publicado en 2014

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group

scientific article published on 18 April 2019

Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1

scientific article published on 01 April 2020

Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. [corrected].

artículo científico publicado en 2015

Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts

scientific article published on 17 September 2019

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease

scientific article published on 07 May 2019

Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations

scientific article published on 11 March 2019

Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

artículo científico publicado en 2016

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management

artículo científico publicado en 2015

EBV-positive diffuse large B-cell lymphoma of the elderly

artículo científico publicado en 2013

Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy

artículo científico publicado en 2019

Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients

scientific article published on 02 April 2020

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

artículo científico publicado en 2015

Evaluation of an Automated Digital Imaging System, Nextslide Digital Review Network, for Examination of Peripheral Blood Smears ⬇️

artículo científico publicado el 1 de junio de 2012

Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations

scientific article published on 26 September 2018

High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome

artículo científico publicado en 2014

High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification

artículo científico publicado en 2019

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma

artículo científico publicado en 2018

Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment

artículo científico publicado en 2018

Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity

artículo científico publicado en 2014

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

scientific article published on 02 September 2018

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

artículo científico publicado en 2021

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2016

Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?

artículo científico publicado en 2014

Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing

artículo científico publicado en 2018

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

artículo científico publicado en 2017

Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features.

artículo científico publicado en 2016

NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

artículo científico publicado en 2017

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

artículo científico publicado en 2014

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

artículo científico publicado en 2014

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

artículo científico publicado en 2015

RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD

scientific article published on 05 December 2019

Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments

scientific article published on 28 March 2019

Single-Cell Quantitative PCR: Advances and Potential in Cancer Diagnostics

artículo científico publicado en 2016

Targeting the programmed death-1 pathway in lymphoid neoplasms.

artículo científico publicado en 2017

The Oncofetal Protein IMP3: A Novel Molecular Marker to Predict Aggressive Meningioma ⬇️

artículo científico publicado el 1 de agosto de 2011

Transient/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies

scientific article published on 18 May 2011

Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection

artículo científico publicado en 2019

Lista de obras de

Aberrant activation of the hedgehog signaling pathway in malignant hematological neoplasms

Acute Myeloid Leukemia and Myelodysplastic Syndromes After Radiation Therapy Are Similar to De Novo Disease and Differ From Other Therapy-Related Myeloid Neoplasms ⬇️

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

Age cutoff in lymphoma diagnosis.

American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma

Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients

Characterization of TP53 mutations in clonal cytopenia of undetermined significance.

Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype

Checkpoint inhibitors in hematological malignancies

Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption

Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group

Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1

Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. [corrected].

Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease

Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations

Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy.

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management

EBV-positive diffuse large B-cell lymphoma of the elderly

Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy

Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Evaluation of an Automated Digital Imaging System, Nextslide Digital Review Network, for Examination of Peripheral Blood Smears ⬇️

Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations

High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome

High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification

High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma

Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment

Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?

Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features.

NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD

Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments

Single-Cell Quantitative PCR: Advances and Potential in Cancer Diagnostics

Targeting the programmed death-1 pathway in lymphoid neoplasms.

The Oncofetal Protein IMP3: A Novel Molecular Marker to Predict Aggressive Meningioma ⬇️

Transient/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies

Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection